T
Tus Pharmaceutical Group Co Ltd
SZSE:000590
Tus Pharmaceutical Group Co Ltd
SZSE:000590
Price:
11.71
CNY
-2.34%
Market Cap:
¥2.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Tus Pharmaceutical Group Co Ltd
SZSE:000590
|
CN |
|
IHS Holding Ltd
NYSE:IHS
|
UK |
|
Le Saunda Holdings Ltd
HKEX:738
|
HK |
|
Denso Corp
TSE:6902
|
JP |
|
G
|
Guangdong Mingzhu Group Co Ltd
SSE:600382
|
CN |
|
Napatech A/S
OSE:NAPA
|
DK |
|
Akatsuki Inc
TSE:3932
|
JP |
|
Cerillion PLC
LSE:CER
|
UK |
|
C
|
Cab Payments Holdings PLC
LSE:CABP
|
UK |
|
Westlife Development Ltd
NSE:WESTLIFE
|
IN |
|
Inspire Medical Systems Inc
NYSE:INSP
|
US |
|
CAP XX Ltd
LSE:CPX
|
AU |
|
S
|
SAH Polymers Ltd
NSE:SAH
|
IN |
|
Manchester United PLC
NYSE:MANU
|
UK |
|
Weilong Grape Wine Co Ltd
SSE:603779
|
CN |
|
N
|
Norsk Solar AS
OSE:NSOL
|
NO |
|
STM Group PLC
LSE:STM
|
IM |
|
S
|
Scherzer & Co AG
XETRA:PZS
|
DE |
|
Zhejiang Huayou Cobalt Co Ltd
SSE:603799
|
CN |
|
X
|
XiAn ChenXi Aviation Technology Corp Ltd
SZSE:300581
|
CN |
Multiples-Based Value
The Multiples-Based Value of one Tus Pharmaceutical Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 11.71 CNY, Tus Pharmaceutical Group Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Tus Pharmaceutical Group Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Tus Pharmaceutical Group Co Ltd Competitors
Tus Pharmaceutical Group Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
T
|
Tus Pharmaceutical Group Co Ltd
SZSE:000590
|
2.8B CNY | 8 | -25.1 | -17.4 | -17.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
847.5B USD | 13 | 41.1 | 27.7 | 29.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD | 6.1 | 21.5 | 14.9 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.3B USD | 4.5 | 16.1 | 10 | 12.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
